Statistical methods for population pharmacokinetic modelling

Statistical Methods in Medical Research

Volumn 7, Issue 1, 1998, Pages 63-84

  Racine Poon, Amy ^a,c   Wakefield, Jon ^b  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b ST MARY S HOSPITAL   (United Kingdom)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BAYES THEOREM; CLINICAL TRIAL; COMPARTMENT MODEL; COVARIANCE; PHARMACOEPIDEMIOLOGY; POPULATION MODEL; REVIEW; STATISTICAL ANALYSIS; STATISTICAL MODEL; VARIANCE;

ANALYSIS OF VARIANCE; ANTICOAGULANTS; ARTHROPLASTY, REPLACEMENT, HIP; BAYES THEOREM; BIOMETRY; CLINICAL TRIALS; HIRUDINS; HUMANS; LIKELIHOOD FUNCTIONS; MODELS, BIOLOGICAL; MODELS, STATISTICAL; NONLINEAR DYNAMICS; PHARMACOKINETICS; RECOMBINANT PROTEINS;

EID: 0031748951     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1191/096228098670696372     Document Type: Review

References (59)

1. Gibaldi M, Perrier D. Drugs and the pharmaceutical sciences. Volume 15: Pharmacokinetics, 2nd edition. New York: Marcel Dekker, 1982.
2. Chi EM Reinsel GC. Models for longitudinal data with random effects and AR(I) errors. Journal of the American Statistical Association 1989; 84: 452-59.
3. Wakefield JC. Bayesian individualization via sampling based methods. Journal of Pharmacokinetics and Biopharmaceutics 1996; 24: 103-31.
4. Steimer J-L, Vozeh S, Racine-Poon A, Holford NHG, O'Neill R. The population approach: rationale, methods and applications in clinical pharmacology and drug development. In: Welling P, Balant H eds. Handbook of experimental pharmacology. New York: Springer, 1994.
5. Wakefield JC, Aarons L, Racine-Poon A. The Bayesian approach to population pharmacokinetic/pharmacodynamic modelling. In: Carlin B et al. Case studies in Bayesian statistics. New York: Springer, 1998.
6. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982; 38: 963-74.
7. Lindstrom MJ, Bates DM. Newton-Raphson and EM algorithms for linear mixed-effects models for repeated-measures data. Journal of the American Statistical Society 1988; 83: 1014-22.
8. Davidian M, Giltinan, DM. Nonlinear models for repeated measures data. London: Chapman & Hall, 1995.
9. Steimer J-L, Mallet A, Golmard JL, Boisieux JF. Alternative approaches to estimation of population pharmacokinetic parameters. Drug Metabolism Reviews 1985; 15: 265-92.
10. Racine-Poon A, Smith AFM. Population models. In: Berry D ed. Statistical methodology in the pharmaceutical sciences. New York: Marcel Dekker, 1990: 139-62.
11. Prévost G. Estimation of a normal probability density function from samples measured with non-negligible and non-constant dispersion. Internal report, Andersa-Gerbios, 2 avenue du 1er mai, F-91120 Palaiseau, 1977.
12. Mentré F, Gomeni R. A two step iterative algorithm for estimation in non-linear mixed effect models with an evaluation in population pharmacokinetics. Journal of Biopharmaceutical Statistics 1995; 5: 141-58.
13. Dempster AP, Laird NM, Rubin DB. Maximum likelihood from incomplete data via the EM algorithm (with discussion). Journal of the Royal Statistical Society, Series B 1977; 39: 1-38.
14. Walker SG. An EM algorithm for nonlinear random effects models. Biometrics 1996; 52: 934-44.
15. Beal SL, Sheiner LB. Estimating population kinetics. CRC Critical Reviews in Biomedical Engineering 1982; 8: 195-222.
16. Beal SL, Sheiner LB. NONMEM User's guide version IV, part vii. Conditional estimation methods. San Francisco, CA: University of California, 1992.
17. Lindstrom MJ, Bates DM. Nonlinear mixed effects model for repeated measures data. Biometrics 1990; 46: 673-87.
18. Wakefield JC, Walker SG. A Bayesian population approach to initial dose selection. Statistics in Medicine 1997; 16: 1135-49.
19. Holford NHG, Sheiner LB. Understanding the dose-effect relationship: clinical application of pharmacokinetic-pharmacodynamic models. Clinical Pharmacokinetics 1981; 6: 429-53.
20. Wolfinger R. Laplace's approximation for nonlinear mixed models. Biometrika 1993; 80: 791-95.
21. Tierney L, Kadane JB. Accurate approximations for posterior moments and marginal densities. Journal of the American Statistical Association 1986; 81: 82-86.
22. Yuh L, Beal SL, Davidian M, Harrison F, Hester A, Kowalski K, Vonesh EF, Wolfinger R. Pppulation pharmacokinetic/ pharmacodynamic methodology and applications: a bibliography. Biometrics 1994; 50: 566-675.
23. Pinheiro JC, Bates DM. Approximations to the loglikelihood function in the nonlinear mixed effects model. Computational and Graphical Statistics 1985; 4: 12-35.
24. Racine-Poon A. A Bayesian approach to nonlinear random effects models. Biometrics 1985; 41: 1015-23.
25. Wakefield JC, Smith AFM, Racine-Poon A, Gelfand AE. Bayesian analysis of linear and non-linear population models using the Gibbs sampler. Applied Statistics 1994; 41: 201-21.
26. Wakefield JC. The Bayesian analysis of population pharmacokinetic models. Journal of the American Statistical Association 1996; 91: 62-75.
27. Smith AFM, Roberts GO. Bayesian computation via the Gibbs sampler and related Markov chain monte Carlo methods. Journal of the Royal Statistical Society, Series B 1993; 55: 3-23.
28. Gelfand AE, Hills SE, Racine A, Smith AFM. Illustration of Bayesian inference in normal data models using Gibbs sampling. Journal of the American Statistical Association 1990; 85: 972-85.
29. Metropolis N, Rosenbluth A, Rosenbluth M, Teller A, Teller E. Equations of state calculations by fast computing machines. Journal of Chemical Physics 1953; 21: 1087-91.
30. Hastings W. Monte Carlo sampling-based methods using Markov chains and their applications. Biometrika 1970; 57: 97-109.
31. Tierney L. Markov chains for exploring posterior distributions. Annals of Statistics 1994; 22: 1701-62.
32. Bennett JE, Racine-Poon A, Wakefield JC. MCMC for nonlinear hierarchical models. In: Gilks WR, Richardson S, Spiegelhalter DJ eds. Markov chain Monte Carlo in practice. London: Chapman & Hall, 1996: 339-59.
33. Best NG, Tan KKC, Gilks WR, Spiegelhalter DJ. Estimation of population pharmacokinetics using the Gibbs sampler. Journal of Pharmacokinetics and Biopharmaceutics 1995; 23: 407-24.
34. Gilks WR, Best NG, Tan KKC. Adaptive rejection metropolis sampling within Gibbs sampling. Applied Statistics 1995; 44: 455-72.
35. Gilks W, Neal R, Best NG, Tan KKC. Corrigendum to 'Adaptive rejection Metropolis sampling within Gibbs sampling'. Applied Statistics 1997; 46: 541-42.
36. Wakefield JC. An expected loss approach to the design of dosage regimens via sampling-based methods. The Statistician 1994; 43: 13-29.
37. Bennett JE, Wakefield JC. A comparison of a Bayesian population method with two methods as implemented in commercially available software. Journal of Pharmacokinetics and Biopharmaceutics 1996; 24: 403-32.
38. Vonesh EF, Chinchilla VM. Linear and nonlinear models for the analysis of repeated measures. New York: Marcel Dekker, 1997.
39. Vonesh EF, Carter RL. Mixed-effects nonlinear regression for unbalanced repeated measures. Biometrics 1992; 48: 1-17.
40. Mallet A. A maximum likelihood estimation method for random coefficient regression models. Biometrika 1986; 73: 645-56.
41. Mentré F, Mallet A. Handling covariates in population pharmacokinetics, International Journal of Bio-Medical Computing 1994; 36: 25-33.
42. Mallet A, Mentré F, Steimer J-L, Lokiec F. Nonparametric maximum likelihood estimation for population pharmacokinetics, with application to cyclosporine. Journal of Pharmacokinetics and Biopharmaceutics 1988; 16: 311-27.
43. Schumitzky A. Nonparametric EM algorithms for estimating prior distributions. Applied Mathematics and Computation 1991; 45: 141-57.
44. Davidian A, Gallant AR. The non-linear mixed effects model with a smooth random effects density. Biometrika 1993; 80: 475-88.
45. Davidian M, Gallant AR. Smooth nonparametric maximum likelihood estimation for population pharmacokinetics, with application to quinidine. Journal of Pharmacokinetics and Biopharmaceutics 1992; 20: 529-62.
46. Wakefield JC, Walker SG. Bayesian nonparametric population models: formulation and comparison with likelihood approaches. Journal of Pharmacokinetics and Biopharmaceutics 1997 (in press).
47. Ferguson TS. Bayesian analysis of some non-parametric problems. Annals of Statistics 1973; 1: 209-30.
48. Antoniak CE. Mixtures of Dirichlet processes with applications to Bayesian non-parametric problems. Annals of Statistics 1974; 2: 1152-74.
49. Escobar MD, West M. Bayesian density estimation and inference using mixtures. Journal of the American Statistical Society 1995; 90: 577-88.
50. Walker SG, Wakefield JC. Population models with a nonparametric random coefficient distribution. Sanhyka 1997 (in press).
51. Muller P, Rosner GL. A Bayesian population model with hierarchical mixture priors applied to blood count data. Journal of the American Statistical Society 1997 (in press).
52. Wakefield JC, Racine-Poon A. An application of Bayesian population pharmacokinetic/ pharmacodynamic models to dose recommendation. Statistics in Medicine 1995; 14: 971-86.
53. Racine-Poon A, Wakefield JC. Bayesian analysis of population pharmacokinetic and instantaneous pharmacodynamic relationships. In: Berry D, Stangl D eds. Bayesian biostatistics. New York: Marcel Dekker, 1996.
54. Racine-Poon A, Botta L, Chang TW et al. Efficacy, pharmacodynamics and pharmacokinetics of GGP 51901, an anti-IgE chimeric monoclonal antibody, in patients with seasonal allergic rhinitis. Journal of Clinical Pharmacology and Therapeutics 1997 (in press).
55. Aarons L, Balant LP, Mentre F, Morselli PL, Rowland M, Steimer J-L, Vozeh S. Practical experience and issues in designing and performing population pharmacokinetic/ pharmacodynamic studies. European Journal of Clinical Pharmacology 1996; 49: 251-54.
56. Mentré F, Mallet A, Baccar D. Optimal design in random-effects regression models. Biometrika 1997; 84: 429-42.
57. Maitre PO, Buhrer M, Thomson D, Stanski DR. A three-step approach to combining Bayesian regression and NONMEM population analysis. Journal of Pharmacokinetics and Biopharmaceutics 1991; 19: 377-84.
58. Mandema J, Verotta D, Sheiner L. Building population pharmacokinetic models - pharmacodynamic models for covariate effects. Journal of Pharmacokinetics and Biopharmaceutics 1992; 20: 511-28.
59. Wakefield JC, Bennett JE. The Bayesian modelling of covariates for population pharmacokinetic models. Journal of the American Statistical Association 1996; 91:917-27.